|
CDC27 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.134600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.110000E-01 |
| Normal-vs-Stage2 |
3.599800E-01 |
| Normal-vs-Stage3 |
1.277160E-01 |
| Normal-vs-Stage4 |
2.104000E-01 |
| Stage1-vs-Stage2 |
2.088800E-01 |
| Stage1-vs-Stage3 |
7.328300E-02 |
| Stage1-vs-Stage4 |
1.944620E-01 |
| Stage2-vs-Stage3 |
8.490600E-01 |
| Stage2-vs-Stage4 |
4.324600E-01 |
| Stage3-vs-Stage4 |
4.269400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.766800E-01 |
| Normal-vs-AfricanAmerican |
7.038400E-01 |
| Normal-vs-Asian |
2.606600E-01 |
| Caucasian-vs-AfricanAmerican |
9.036800E-01 |
| Caucasian-vs-Asian |
1.353350E-01 |
| AfricanAmerican-vs-Asian |
1.448030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.966600E-01 |
| Normal-vs-Female |
1.986960E-04 |
| Male-vs-Female |
1.53850999999872E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.011600E-01 |
| Normal-vs-Extreme_Weight |
1.979590E-01 |
| Normal-vs-Obese |
3.039600E-01 |
| Normal-vs-Extreme_Obese |
4.241600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.425990E-01 |
| Normal_Weight-vs-Obese |
8.671200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.542600E-01 |
| Extreme_Weight-vs-Obese |
5.116200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.256800E-01 |
| Obese-vs-Extreme_Obese |
2.744400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.580400E-03 |
| Normal-vs-Age(41-60Yrs) |
4.441600E-02 |
| Normal-vs-Age(61-80Yrs) |
4.157600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.475400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.425000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.01480000000731E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.643900E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.121300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.344090E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.762410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.415600E-01 |
| Normal-VS-Type2 PRCC |
5.902000E-01 |
| Normal-VS-KIRP CIMP |
9.352800E-04 |
| Normal-VS-Unclassified PRCC |
2.165000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.864600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.11369996452981E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
1.758620E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.12419999999769E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.419000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.213000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.304000E-01 |
| Normal-vs-N1 |
5.560300E-03 |
| Normal-vs-N2 |
3.026800E-01 |
| N0-vs-N1 |
2.835500E-03 |
| N0-vs-N2 |
2.635800E-01 |
| N1-vs-N2 |
9.362400E-01 |
|
|
